Abrdn Life Sciences Investors

(NYSE) HQL

Current Price$19.12

Market Cap$578.66M

Since IPO (1992)+2,216%

5 Year+58%

1 Year+71%

1 Month+10%

Abrdn Life Sciences Investors Financials at a Glance

Market Cap

$578.66M

Revenue (TTM)

$79.82M

Net Income (TTM)

$185.97M

EPS (TTM)

$6.68

P/E Ratio

2.85

Dividend

$2.04

Beta (Volatility)

0.74 (Low)

Dividend

$2.04

Beta (Volatility)

0.74 (Low)

Price

$19.12

Volume

1,482

Open

$19.37

Price

$19.12

Volume

1,482

Open

$19.37

Previous Close

$19.12

Daily Range

$19.07 - $19.37

52-Week Range

$12.71 - $19.37

Estimated Earnings Date

Jun 24, 2025

Dividend

$2.04

Beta (Volatility)

0.74 (Low)

Price

$19.12

Volume

1,482

Open

$19.37

Previous Close

$19.12

Daily Range

$19.07 - $19.37

52-Week Range

$12.71 - $19.37

Estimated Earnings Date

Jun 24, 2025

HQL News

The Best ETF for 2007: H&Q Life Sciences Investors

Jim FinkNov 16, 2006

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Abrdn Life Sciences Investors

Industry

Capital Markets

Sector

Financials

Website

www.teklacap.com/hql.html

Headquarters

Philadelphia, MA 02110, US

HQL Financials

Key Financial Metrics (TTM)

Gross Margin

90.69%

Operating Margin

331.92%

Net Income Margin

331.92%

Return on Equity

36.89%

Return on Capital

16.66%

Return on Assets

35.18%

Earnings Yield

35.09%

Dividend Yield

10.72%

Payout Ratio

25.13%

Stock Overview

Market Cap

$578.66M

Shares Outstanding

30.41M

Volume

1.48K

Avg. Volume

109.44K

Financials (TTM)

Gross Profit

$71.73M

Operating Income

$149.67M

EBITDA

$185.97M

Operating Cash Flow

-$3.54M

Capital Expenditure

-$4.00

Free Cash Flow

-$3.54M

Cash & ST Invst.

$851.60K

Total Debt

$0.00

Abrdn Life Sciences Investors Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$48.07M

+2227.6%

Gross Profit

$44.95M

+2076.6%

Gross Margin

93.52%

N/A

Market Cap

$578.66M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$65.34M

+30.0%

EBITDA

$65.34M

-35.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$851.60K

-93.8%

Total Debt

$0.00

N/A

Accounts Receivable

$1.28M

+1030.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

35.18%

N/A

Return on Invested Capital

35.18%

N/A

Free Cash Flow

-$1.22M

N/A

Operating Cash Flow

-$1.22M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GAINGladstone Investment Corp.

GAINGladstone Investment Corp.$15.16+1.74%

ECCEagle Point Credit Company Inc.

ECCEagle Point Credit Company Inc.$3.70-0.27%

GLADGladstone Capital Corporation

GLADGladstone Capital Corporation$18.96+1.17%

CCAPCrescent Capital BDC, Inc.

CCAPCrescent Capital BDC, Inc.$11.12+1.46%

SORSource Capital, Inc.

SORSource Capital, Inc.$44.90-0.24%

MCIBarings Corporate Investors

MCIBarings Corporate Investors$17.42-0.23%

CIONCION Investment Corporation

CIONCION Investment Corporation$6.12+1.83%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

ONDSOndas

ONDSOndas$7.83+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$17.88+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

WENWendy's

WENWendy's$7.80+0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.31+0.05%

Questions About HQL

What is the current price of Abrdn Life Sciences Investors?

Abrdn Life Sciences Investors is trading at $19.12 per share.

What is the 52-week range for Abrdn Life Sciences Investors?

Over the past 52 weeks, Abrdn Life Sciences Investors has traded between $12.71 and $19.37.

How much debt does Abrdn Life Sciences Investors have?

As of the most recent reporting period, Abrdn Life Sciences Investors reported total debt of $0.00.

How much cash does Abrdn Life Sciences Investors have on hand?

Abrdn Life Sciences Investors reported $75.54K in cash and cash equivalents in its most recent financial results.

What is Abrdn Life Sciences Investors’s dividend yield?

Abrdn Life Sciences Investors currently has a dividend yield of 10.72%.

Abrdn Life Sciences Investors

Abrdn Life Sciences Investors Financials at a Glance

HQL News

The Best ETF for 2007: H&Q Life Sciences Investors

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Abrdn Life Sciences Investors

HQL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Abrdn Life Sciences Investors Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HQL

What is the current price of Abrdn Life Sciences Investors?

What is the 52-week range for Abrdn Life Sciences Investors?

How much debt does Abrdn Life Sciences Investors have?

How much cash does Abrdn Life Sciences Investors have on hand?

What is Abrdn Life Sciences Investors’s dividend yield?

Premium Investing Services